Chinese Traditional and Herbal Drugs
|
2025, 56(6): 1989-1998
Exploring protective mechanism of luteolin against LPS/ATP-induced pyroptosis based on NLRP3/Caspase-1/GSDMD pathway
Full
LIU Shuanghui1,2, ZHANG Yankun1,2, ZHAO Yi1,2, HE Changliang3,1
Affiliations
1 Natural Medicine Research Center, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China;
2 Department of Basic Veterinary, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China;
3 Department of Clinical Veterinary, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611134, China
doi: 10.7501/j.issn.0253-2670.2025.06.012
Outline
Objective Based on NOD-like receptor thermal protein domain associated protein 3 (NLRP3)/cysteinyl aspartate specific proteinase-1 (Caspase-1)/Gasdermin D (GSDMD) pathway to study the intervention effect of luteolin on lipopolysaccharide (LPS) combined with adenosine triphosphate (ATP)-induced pyroptosis in J774A.1 cells and its mechanism. Methods Molecular docking technology was used to predict the possibility of luteolin binding to pyroptosis-related proteins. Mouse mononuclear macrophage J774A.1 cells in logarithmic growth phase were divided into control group, LPS+ATP group, luteolin (8 μmol/L) group, and luteolin low, medium, and high (2, 4, and 8 μmol/L) + LPS + ATP groups. LPS + ATP was used to induce pyroptosis in J774A.1 cells, and luteolin was used for preventive treatment for 12 h. Cell viability and cell membrane damage were detected by propidium iodide (PI) staining, lactate dehydrogenase (LDH) release, and cell counting kit-8 (CCK-8) method. The levels of interleukin-1β (IL-1β) and IL-18 were determined by ELISA. Western blotting was used to detect the protein expressions of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), Caspase-1, and GSDMD in cells. At the same time, ICR male mice were randomly divided into a control group, an LPS (50 mg/kg) group, a luteolin alone (80 mg/kg) group, and a luteolin low-, medium-, and high-dose (40, 60, and 80 mg/kg) + LPS (50 mg/kg) group. An in vivo experiment was performed to investigate the intervention of luteolin in LPS-induced pyroptosis of mouse spleen cells. The levels of IL-1β and IL-18 in serum and the expressions of NLRP3, ASC, Caspase-1, and GSDMD in spleen were detected. Results The results of molecular docking showed that luteolin had good binding activity with pyroptosis-related proteins Caspase-1, NLRP3, ASC and GSDMD, and the binding energy was less than −5 kcal/mol. In vitro experiments showed that 12 hours of luteolin pretreatment (2—8 μmol/L) significantly increased the cell viability induced by LPS + ATP (P < 0.05), significantly reduced the positive rate of PI staining and LDH release (P < 0.05), significantly reduced the release of IL-1β and IL-18 (P < 0.01), and significantly down-regulated the expression of NLRP3, Caspase-1 p10 and GSDMD p30 (P < 0.01). In vivo experiments showed that luteolin could significantly reduce the release of IL-1β and IL-18 in serum (P < 0.01) and significantly down-regulate the expression of NLRP3, Caspase-1 p20 and GSDMD p30 (P < 0.01). Conclusion Luteolin can significantly improve the morphological damage of LPS + ATP-induced J774A.1 cell pyroptosis, inhibit the release of the pro-inflammatory cytokine IL-1β and IL-18, and inhibit the occurrence of pyroptosis through the NLRP3/Caspase-1/GSDMD signaling pathway.
pyroptosis
/
luteolin
/
NOD-like receptor thermal protein domain associated protein 3
/
cystein-asparate protease-1
/
gasdermin D
刘双慧, 张衍坤, 赵毅, 贺常亮.
基于NLRP3/Caspase-1/GSDMD通路探讨木犀草素对LPS/ATP诱导的细胞焦亡的保护机制.
中草药,
2025
, 56
(6)
: 1989
-1998
.
DOI: 10.7501/j.issn.0253-2670.2025.06.012
LIU Shuanghui, ZHANG Yankun, ZHAO Yi, HE Changliang.
Exploring protective mechanism of luteolin against LPS/ATP-induced pyroptosis based on NLRP3/Caspase-1/GSDMD pathway[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(6)
: 1989
-1998
.
DOI: 10.7501/j.issn.0253-2670.2025.06.012
Year 2025 volume 56 Issue 6
45
8
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.06.012
- Receive Date:2024-11-14
- Online Date:2026-11-13